Company: INDP
Filing Date: 2025-07-16
Form Type: 8-K
Source: 0001641172-25-019893
Chunk: 0

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-07-16
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events.

As
previously reported on January 31, 2025, Indaptus Therapeutics, Inc. (the “ Company”)
was notified, or the Notification Letter, by the Nasdaq Listing Qualifications that it was not in compliance with the minimum bid price
requirements set forth in Nasdaq Listing Rule 5550(a)(2), or the Rule, for continued listing on The Nasdaq Capital Market. hat the Company had 180 calendar days, or until July 30, 2025,

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
July 16,2025

  INDAPTUS                                   
  By:                     /s/                
  Name:                   Nir                
  Title:                  Chief